The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome

Iranian Journal of Reproductive Medicine

Volumn 12, Issue 12, 2014, Pages 811-816

  Rahiminejad, Mohammad Ehsan ^a   Moaddab, Amirhossein ^b   Rabiee, Soghra ^a   Esna Ashari, Farzaneh ^a   Borzouei, Shiva ^a   Hosseini, Seyyed Mohammad ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Complication; Depression; Hirsutism; Obesity; Polycystic ovary syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MARKER; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DYSTHYMIA; FEMALE; FEMALE INFERTILITY; HIRSUTISM; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OVARY POLYCYSTIC DISEASE; TESTOSTERONE BLOOD LEVEL;

EID: 84924558366     PISSN: 16806433     EISSN: 20082177     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.
2. MarchWA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551.
3. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41.
4. Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010; 94:1565-1574.
5. Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012; 18: 638-651.
6. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2011; 26: 2442-2451.
7. Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88:5801-5807.
8. McCook JG, Reame NE, Thatcher SS. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2005; 34: 12-20.
9. Dokras A. Mood and anxiety disorders in women with PCOS. Steroids 2012; 77: 338-341.
10. Meyer C. Depressive disorders were the fourth leading cause of global disease burden in the year 2000. Evid Based Ment Health 2004; 7: 123.
11. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
12. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097-1106.
13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 2003; 289: 3095-3105.
14. Sadeghirad B, Haghdoost AA, Amin-Esmaeili M, Shahsavand Ananloo E, Ghaeli G, Rahimi-Movaghar A, et al. Epidemiology of major depressive disorder in Iran: a systematic review and meta-analysis. Int J Prev Med 2010; 1: 81-91.
15. Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 2011; 26: 3339-3345.
16. Shakerardekani Z, Nasehi AA, Eftekhar T, Ghaseminezhad A, Ardekani MA, Raisi F. Evaluation of depression and mental health status in women with polycystic ovary syndrome. J Fam Reprod Health 2011; 5: 67-71.
17. Broekmans FJ, Fauser BC. Diagnostic criteria for polycystic ovarian syndrome. Endocrine 2006; 30: 3-11.
18. Benazzi F. Various forms of depression. Dialogues Clin Neurosci 2006; 8: 151-161.
19. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007; 87: 1369-1376.
20. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009; 91: 207-212.
21. Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011; 117: 145-152.
22. Dixon JB, Dixon ME, O’Brien PE. Depression in association with severe obesity. Arch Intern Med 2003;163: 2058-2065.
23. Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al: Depression in women with polycystic ovary syndrome Clinical and biochemical correlates. J Affect Disord 2003; 74: 299-304.
24. Trent M, Austin SB, Rich M, Gordon CM. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005; 5: 107-111.
25. Bhattacharya SM, Jha A. Prevalence and risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2010; 94: 357-359.
26. Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000; 49: 1255-1260.
27. Adriaanse MC, Dekker JM, Nijpels G, Heine RJ, Snoek FJ, Pouwer F. Associations between depressive symptoms and insulin resistance: the Hoorn Study. Diabetologia 2006; 49: 2874-2877.
28. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, rostenedione and dihydrotestosterone concentrations are of elevated in female patients with major depression. Psychoneuroendocrinology 2000; 25: 765-771.
29. Kurita H, Maeshima H, Kida S, Matsuzaka H, Shimano T, Nakano Y, et al. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord 2013; 146: 205-212.
30. Adali E, Yildizhan R, Kurdoglu M, Kolusari A, Edirne T, Sahin HG, et al. The relationship between clinicobiochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome. J Int Med Res 2008; 36: 1188-1196.